Ascentage Pharma Competitors and Similar CompaniesClear all

Ascentage Pharma's competitors and similar companies include Symphogen, Epizyme, Janssen and Loxo Oncology.

	Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.	Symphogen Symphogen is a biotech company focused on oncology and immuno-oncology.	Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.	Janssen Janssen is a company providing prescription pharmaceutical products.	Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date	Founding Date 2017	Founding Date 2000	Founding Date 2007	Founding Date 1953	Founding Date 2013
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US	Locations Ballerup, DK HQ Somerville, US	Locations Cambridge, US HQ	Locations Raritan, US HQ Vienna, AT Prague, CZ Espoo, FI Budapest, HU Oslo, NO Belgrade, RS see more	Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US
Employees	Employees 567	Employees 196	Employees 20364% increase	Employees 17,3684% decrease	Employees 65610% decrease
Financial
Revenue (est.)	Revenue (est.) ¥574.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $37.4m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥48.9m (FY, 2025)	Cost of goods N/A	Cost of goods $10.5m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Net income	Net income (¥1.2b) (FY, 2025)	Net income N/A	Net income ($251.1m) (FY, 2021)	Net income N/A	Net income ($148.9m) (FY, 2017)
Funding
Total funding raised	Total funding raised $ 237.5m	Total funding raised $ 387.2m	Total funding raised $ 51.5m	Total funding raised N/A	Total funding raised $ 57m